Unlike previous GLP-1s that worked on one or two hormone receptors, Retarditude works on three
The drugs are contraindicated in pregnant women due to risk of developmental abnormalities in the foetus
Cardiovascular benefits The SELECT trial a landmark cardiovascular outcomes study involving over 17,000 participants showed that semaglutide reduced the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) by 20% in people with obesity who did not have diabetes
Look for specific weight-loss thresholds, time windows, and required adherence conditions
Kiwifruit has emerged as a surprising star
Jeffrey Egler, MD, is a double board-certified physician in Family Medicine and Lifestyle Medicine